EEG-β/γ spectral power elevation in rat: a translatable biomarker elicited by GABAAα2/3-positive allosteric modulators at nonsedating anxiolytic doses
- 1 January 2015
- journal article
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 113 (1) , 116-131
Abstract
Benzodiazepine drugs, through interaction with GABAAα1, GABAAα2,3, and GABAAα5subunits, modulate cortical network oscillations, as reflected by a complex signature in the EEG power spectrum. Recent drug discovery efforts have developed GABAAα2,3-subunit-selective partial modulators in an effort to dissociate the side effect liabilities from the efficacy imparted by benzodiazepines. Here, we evaluated rat EEG and behavioral end points during dosing of nine chemically distinct compounds that we confirmed statistically to selectively to enhance GABAAα2,3-mediated vs. GABAAα1or GABAAα5currents in voltage clamped oocytes transfected with those GABAAsubunits. These compounds were shown with in vivo receptor occupancy techniques to competitively displace [3H]flumazenil in multiple brain regions following peripheral administration at increasing doses. Over the same dose range, the compounds all produced dose-dependent EEG spectral power increases in the β- and and γ-bands. Finally, the dose range that increased γ-power coincided with that eliciting punished over unpunished responding in a behavioral conflict model of anxiety, indicative of anxiolysis without sedation. EEG γ-band power increases showed a significant positive correlation to in vitro GABAAα2,3modulatory intrinsic activity across the compound set, further supporting a hypothesis that this EEG signature was linked specifically to pharmacological modulation of GABAAα2,3signaling. These findings encourage further evaluation of this EEG signature as a noninvasive clinical translational biomarker that could ultimately facilitate development of GABAAα2,3-subtype-selective drugs for anxiety and potentially other indications.Keywords
This publication has 39 references indexed in Scilit:
- A Comparison of the 2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic PainAdvances in Pharmacological Sciences, 2011
- Development and SAR of functionally selective allosteric modulators of GABAA receptorsBioorganic & Medicinal Chemistry, 2011
- Parvalbumin neurons and gamma rhythms enhance cortical circuit performanceNature, 2009
- Driving fast-spiking cells induces gamma rhythm and controls sensory responsesNature, 2009
- Perisomatic InhibitionNeuron, 2007
- The gamma cycleTrends in Neurosciences, 2007
- Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Electroencephalogram Effects of GABAA Receptor Modulators: In Vitro-in Vivo CorrelationsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Standard Operating Procedure for the Registration and Computer-Supported Evaluation of Pharmaco-EEG DataNeuropsychobiology, 1995
- Benzodiazepine receptor binding with [3H]-Ro 15-1788Life Sciences, 1985
- Animal models for the study of anti-anxiety agents: A reviewNeuroscience & Biobehavioral Reviews, 1985